Escalon Medical Corp 的盈利质量评分为 B+/52.98418。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Escalon Medical Corp 何时发布财报?
Escalon Medical Corp 的下一份财报预计在 发布
Escalon Medical Corp 的预期收益是多少?
根据华尔街分析师的预测,Escalon Medical Corp 的预期收益为 $
Escalon Medical Corp 是否超出收益预期?
Escalon Medical Corp 最近的收益为 $, 预期。
关键数据
前收盘价
$0.2
开盘价
$0.18
当日区间
$0.18 - $0.205
52周范围
$0.1001 - $0.4625
交易量
16.8K
平均成交量
21.9K
股息收益率
--
每股收益(TTM)
-0.05
市值
$1.4M
什么是 ESMC?
Escalon Medical Corp. engages in the development, manufacture, marketing, and distribution of medical devices for ophthalmic applications. The company is headquartered in Wayne, Pennsylvania and currently employs 39 full-time employees. The firm and its products are subject to regulation and inspection by the United States Food and Drug Administration. Its products are A-Scans, B-Scans, UBM, Pachymeters, Ispan Intraocular Gases, Surgical Packs and AXIS Image Management. A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. UBM is a high frequency/high resolution ultrasound device. AXIS Image Management system manages ophthalmic diagnostic images via a Web browser from any device regardless of modality, device manufacturer or location.